Induction of B cell costimulatory function by recombinant murine CD40 ligand. 1994

M K Kennedy, and K M Mohler, and K D Shanebeck, and P R Baum, and K S Picha, and C A Otten-Evans, and C A Janeway, and K H Grabstein
Department of Immunobiology, Immunex Research and Development Corporation, Seattle, WA 98101.

T cell-dependent regulation of B cell growth and differentiation involves an interaction between CD40, a B cell surface molecule, and the CD40 ligand (CD40L) which is expressed on activated CD4+ T cells. In the current study, we show that recombinant membrane-bound murine CD40L induces B cells to express costimulatory function for the proliferation of CD4+ T cells. CD40L- or lipopolysaccharide (LPS)-activated, but not control-cultured B cells were strong costimulators of anti-CD3 or alloantigen-dependent T cell responses. The molecular interactions responsible for the increased costimulatory functions were examined by analyzing the activated B cells for changes in the expression of two costimulatory molecules, B7 and heat-stable antigen (HSA), as well as by the use of antagonists of B7 and HSA (CTLA4.Fc and 20C9, respectively). The expression of both B7 and HSA was enhanced on B cells activated with LPS. As observed in previous studies, the costimulatory activity of the LPS-activated B cells was dependent on both B7 and HSA and was completely inhibited in the presence of a combination of CTLA4.Fc and 20C9. In contrast, activation of B cells with CD40L induced the expression of B7 but did not enhance the expression of HSA. In addition the costimulatory activity of the CD40L-activated B cells was partially, but not completely, inhibited by the combination of CTLA4.Fc and 20C9. These results demonstrate that CD40L regulates costimulatory function of B cells in part by inducing the expression of B7 and suggest that CD40L-activated B cells express an additional costimulatory activity that is not associated with LPS-activated B cells.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000943 Antigens, Differentiation Antigens expressed primarily on the membranes of living cells during sequential stages of maturation and differentiation. As immunologic markers they have high organ and tissue specificity and are useful as probes in studies of normal cell development as well as neoplastic transformation. Differentiation Antigen,Differentiation Antigens,Differentiation Antigens, Hairy Cell Leukemia,Differentiation Marker,Differentiation Markers,Leu Antigen,Leu Antigens,Marker Antigen,Marker Antigens,Markers, Differentiation,Antigen, Differentiation,Antigen, Leu,Antigen, Marker,Antigens, Leu,Antigens, Marker,Marker, Differentiation

Related Publications

M K Kennedy, and K M Mohler, and K D Shanebeck, and P R Baum, and K S Picha, and C A Otten-Evans, and C A Janeway, and K H Grabstein
November 1995, Current biology : CB,
M K Kennedy, and K M Mohler, and K D Shanebeck, and P R Baum, and K S Picha, and C A Otten-Evans, and C A Janeway, and K H Grabstein
September 1995, Journal of immunology (Baltimore, Md. : 1950),
M K Kennedy, and K M Mohler, and K D Shanebeck, and P R Baum, and K S Picha, and C A Otten-Evans, and C A Janeway, and K H Grabstein
May 1993, European journal of immunology,
M K Kennedy, and K M Mohler, and K D Shanebeck, and P R Baum, and K S Picha, and C A Otten-Evans, and C A Janeway, and K H Grabstein
November 1996, Proceedings of the National Academy of Sciences of the United States of America,
M K Kennedy, and K M Mohler, and K D Shanebeck, and P R Baum, and K S Picha, and C A Otten-Evans, and C A Janeway, and K H Grabstein
January 2007, Journal of immunology (Baltimore, Md. : 1950),
M K Kennedy, and K M Mohler, and K D Shanebeck, and P R Baum, and K S Picha, and C A Otten-Evans, and C A Janeway, and K H Grabstein
October 1994, Seminars in immunology,
M K Kennedy, and K M Mohler, and K D Shanebeck, and P R Baum, and K S Picha, and C A Otten-Evans, and C A Janeway, and K H Grabstein
March 1996, International immunology,
M K Kennedy, and K M Mohler, and K D Shanebeck, and P R Baum, and K S Picha, and C A Otten-Evans, and C A Janeway, and K H Grabstein
April 1997, Annals of the New York Academy of Sciences,
M K Kennedy, and K M Mohler, and K D Shanebeck, and P R Baum, and K S Picha, and C A Otten-Evans, and C A Janeway, and K H Grabstein
May 1997, Journal of immunology (Baltimore, Md. : 1950),
M K Kennedy, and K M Mohler, and K D Shanebeck, and P R Baum, and K S Picha, and C A Otten-Evans, and C A Janeway, and K H Grabstein
December 1992, The Journal of experimental medicine,
Copied contents to your clipboard!